Evidence map›Paper›PMID 40667170›Full record

ArticlebioRxiv : the preprint server for biology2025

Maggie Musick, Chinasa A Ufondu, Carmen E Rowland, Joseph L Sottnik, Madeleine T Shackleford, Camryn S Nesiba, Julie H Ostrander, Matthew J Sikora

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maggie MusickDepartment of Pathology, University of Colorado Anschutz Medical Campus.ORCID 0000-0002-3564-2527
Chinasa A UfonduDepartment of Pharmacology, Molecular Pharmacology and Therapeutics (MPaT), University of Minnesota, Twin Cities.
Carmen E RowlandDepartment of Pathology, University of Colorado Anschutz Medical Campus.
Joseph L SottnikDepartment of Pathology, University of Colorado Anschutz Medical Campus.
Madeleine T ShacklefordDepartment of Pathology, University of Colorado Anschutz Medical Campus.
Camryn S NesibaDepartment of Pathology, University of Colorado Anschutz Medical Campus.
Julie H OstranderMasonic Cancer Center, University of Minnesota, Twin Cities.
Matthew J SikoraDepartment of Pathology, University of Colorado Anschutz Medical Campus.ORCID 0000-0003-2915-7442

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Training Program in Cancer BiologyT32CA190216 · NCI · UNIVERSITY OF COLORADO DENVER · PI Craig T. Jordan · 2016 to 2026
$3.5M
NCI NIH HHS P30 CA046934NCI NIH HHS T32 CA190216
6 · The paper itself

Abstract

Invasive lobular carcinoma (ILC) is a common subtype of breast cancer that is defined in part by genetic loss of

Indexed as

breast cancerCDH1E-cadherinEMTetiologyInvasive lobular carcinomamammary glandoncogenesis

Identifiers

PMID40667170
PMCPMC12262285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.